Trial Profile
A randomized trial to investigate the efficacy of erythropoietin in patients undergoing hematopoietic cell transplantation
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Dec 2015
Price :
$35
*
At a glance
- Drugs Erythropoietin (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- 01 Dec 2015 New trial record